CAPTRUST FINANCIAL ADVISORS

Position in FTRE — Fortrea Holdings Inc.

CIK 1512024 RALEIGH, NC

Position in FTRE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,247,396

-$474,171 QoQ

Shares Held

132,420

+32.7% QoQ

Ownership

0.140%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 12.267784322609877.ToString("F0")% Shared 0.ToString("F0")% None 87.73221567739013.ToString("F0")%

Healthcare · as of Mar 31, 2026

CAPTRUST FINANCIAL ADVISORS holds $130,226,430 across 94 Biotechnology names. FTRE ranks #16 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	38,502	$29,748,185
2	VRTX	Vertex Pharmaceuticals Inc / Ma	32,092	$14,330,361
3	EXEL	Exelixis, Inc.	312,296	$13,394,375
4	HALO	Halozyme Therapeutics, Inc.	121,088	$7,825,917
5	CELC	Celcuity Inc.	61,068	$6,970,301
6	RPRX	Royalty Pharma plc	143,760	$6,896,167
7	LGND	Ligand Pharmaceuticals Inc	29,900	$5,969,535
8	INCY	Incyte Corp	53,555	$5,040,596

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,247,396	132,420	+32.7%	Shares	Sole	2026-05-15
2025-12-31	$1,721,567	99,801	+180.2%	Shares	Sole	2026-02-17
2025-09-30	$299,911	35,619	-17.5%	Shares	Sole	2025-11-19
2025-06-30	$213,165	43,151	+271.5%	Shares	Sole	2025-08-15
2025-03-31	$87,700	11,616	-5.1%	Shares	Sole	2025-05-15
2024-12-31	$228,257	12,239	-6.8%	Shares	Sole	2025-02-14
2024-09-30	$262,700	13,135	-45.6%	Shares	Sole	2024-11-14
2024-06-30	$563,917	24,161	-16.4%	Shares	Sole	2024-08-15
2024-03-31	$1,160,206	28,904	-14.4%	Shares	Sole	2024-05-15
2023-12-31	$1,178,991	33,782	-13.4%	Shares	Sole	2024-02-14
2023-09-30	$1,115,781	39,027	—	Shares	Sole	2023-11-15
No filing history on record for this holder in this stock.